GLAUCOMA 360

Opening Remarks and Keynote Lecture from the 10th Annual Glaucoma 360 New Horizons Forum. New Horizons unites key clinical, industry, financial, and FDA leaders in a unique exchange on research innovation and advances in glaucoma treatment. The 2021 meeting was presented as a global virtual event. Welcome remarks by Adrienne L. Graves, PhD and Andrew G. Iwach, MD, Co-Founders and Co-Chairs of Glaucoma 360.

6:40 - Opening Keynote Address (Drs. Henry and Frederick Sutro Memorial Lecture) —
"Glaucoma: What predictions came true?" presented by George A. Cioffi, MD,
Edward S. Harkness Chairman and Ophthalmologist-in-Chief of the Department of Ophthalmology, New York-Presbyterian Hospital, Columbia University Medical Center.

Glaucoma 360 New Horizons Forum took place on January 30, 2021. This session, Healthcare Delivery, Pandemic and Beyond, features moderators Ruth Williams, MD, glaucoma specialist at Wheaton Eye Clinic, and Anup K. Khatana, MD, Medical Director at Cincinnati Eye Institute.

Speakers:
Hunter Cherwek, MD, Vice President, Clinical Services, Orbis: “Cybersight Telemedicine and Other Innovations: A Global Perspective"
S. Fabian Lerner, MD, Professor of Ophthalmology, Favaloro University, Buenos Aires, Argentina: "Glaucoma care after COVID: A Pan-American Perspective"
Oluwatosin Smith, MD, Ophthalmologist, Glaucoma Associates of Texas, Associate Professor of Ophthalmology UT Southwestern Medical Center: "The New Normal: Updated Workflows in Glaucoma Practices"
Ningli Wang, MD, PhD, Director and Vice President, Eye Center of Beijing Tongren Hospital, Beijing: "COVID Pandemic and Effects on Ophthalmology Delivery Systems"
John Cropsey, MD, Clinical Professor Hope Africa University Medical School and Director of Hope Africa Eye Care International Referral Center, Kibuye, Burundi: "COVID and Post-COVID Ophthalmic Care in Central Africa"

Audience Q&A — Glaucoma 360 is presented annually by Glaucoma Research Foundation in San Francisco, CA. glaucoma360.org

"New Horizons in Glaucoma Diagnostics" is a session from the New Horizons Forum presented on January 30, 2021 by Glaucoma Research Foundation.
Moderators:
Ranya Habash, MD
Microsoft AI for Health, FDA Digital Health Network of Experts; Medical Director of Technology Innovation, Assistant Professor of Clinical Ophthalmology, Bascom Palmer Eye Institute
Michael Waisbourd, MD
Director, Glaucoma Research Center, Tel Aviv Medical Center, Israel , Clinical Associate Professor of Ophthalmology, Tel Aviv University, Israel

Panelists:
Lama Al-Aswad, MD, MPH
Vice Chair of Innovations, Langone Department of Ophthalmology; Professor of Ophthalmology and Director of Tele-Ophthalmology, Artificial Intelligence and Innovations NYU Langone Eye Center
L. Jay Katz, MD
Director Emeritus Glaucoma Service, Wills Eye Hospital and Chief Medical Officer Glaukos
Andrew J. Tatham, MD, MBA, MBChB(Hons), FRCSEd, FRCOphth, FEBO, FEBOS-CR
Consultant Ophthalmologist, Princess Alexandra Eye Pavilion, NHS Scotland Research Clinician, University of Edinburgh

Presenting Companies:
Diopsys Inc., Matthew Emmer, VP of Business Development & Clinical Affairs
Eyenuk Inc., Kaushal Solanki, PhD, CEO and Founder
Google, Naama Hammel, MD, Clinical Research Scientist
Heru, Mohamed Abou Shousha, MD, MS, FRCS, PhD, CEO and Founder
Keep Your Sight, Elina Ianchulev, MBA, Chief Business Officer
Ocutrx Vision Technologies, Linda A. Lam, MD, MBA, Chief Scientific and Strategy Officer

Audience Q&A

"New Horizons in Glaucoma Therapeutics" is a session from the virtual New Horizons Forum presented on January 30, 2021 by Glaucoma Research Foundation.
Moderators:
Ahmara Gibbons Ross, MD, PhD
Assistant Professor of Ophthalmology and Neurology, Hospital of the University of Pennsylvania
Inder Paul Singh, MD
President, The Eye Centers of Racine & Kenosha

Speakers:
John Berdahl, MD, Founder and Chief Medical Officer, Equinox
Robert Dempsey, MBA, Chief Executive Officer, TearClear
Adriana Di Polo, PhD, Professor, Department of Neuroscience, University of Montreal and Axe neurosciences, CRCHUM
Kimberly Gokoffski, MD, PhD, Assistant Professor of Clinical Ophthalmology, USC Roski Eye Institute
Michael Goldstein, MD, MBA, President, Ophthalmology and Chief Medical Officer, Ocular Therapeutix
Laurence Marsteller, MSc, MD, Founder, Chairman and CEO, Radiance Therapeutics
Larry Brown, Chief Scientific Officer and David Steed, MD, Executive VP, Medical Affairs and Chief Medical Officer, Noveome Biotherapeutics Inc.
Cynthia Yu-Wai-Man, MD PhD, Principal Investigator, Nanogenics

Audience Q&A

"Global Innovations" is a session from the Glaucoma 360 New Horizons Forum presented on January 30, 2021 by Glaucoma Research Foundation.

Moderators:
Malik Y. Kahook, MD
The Slater Family Endowed Chair in Ophthalmology; Vice Chair, Clinical & Translational Research; Chief, Glaucoma Service & Director, Glaucoma Fellowship, University of Colorado Anschutz Medical Campus Department of Ophthalmology
Suman S. Thapa, MD, PhD
Professor of Ophthalmology and Director, Research and Glaucoma, Tilganga Institute of Ophthalmology, Kathmandu, Nepal

Panelists:
Sahar Bedrood, MD, PhD, Partner and Ophthalmologist, Acuity Eye Group
Pearse Keane, MD, Ophthalmologist, Moorfields Eye Hospital
Kaweh Mansouri, MD, PhD, Ophthalmologist, Glaucoma Centre, Montchoisi Clinic, Lausanne, Switzerland
Nathan M. Radcliffe, MD, Glaucoma Specialist, New York Eye Surgery Center

Presenting Companies:
Avisi Technologies Inc., Rui Jing Jiang, CEO and Co-Founder, USA
Bionode, Jane Fischer, President and Chief Executive Officer, USA
Implandata Ophthalmic Products, Max Ostermeier, MBA, CEO and Founder, Germany
InjectSense, Ariel Cao, President/CEO and Co-Founder, USA
Novai, Daria Gerasimova, Business Development Manager, United Kingdom
Olleyes, Inc., Alberto Gonzalez-Garcia, MD, Chief Executive Officer, USA
Remidio, Divya Rao, MD, Medical Director, India

Audience Q&A

"The Future of Innovations" is a session from the Glaucoma 360 New Horizons Forum presented on January 30, 2021 by Glaucoma Research Foundation.
Speakers:
Ike Ahmed, MD, FRCSC
Cataract and Glaucoma Specialist, Prism Eye Institute, Canada: “Raising the Bar on IOP Assessment"
Prof. M. Francesca Cordeiro, MD, PhD
Professor of Ophthalmology, UCL and Imperial College London, Western Eye Hospital London, United Kingdom:“Innovations in Advanced Glaucoma: It’s Now or Never”
Augusto Azuara-Blanco, PhD FRCS (Ed), FRCOphth
Clinical Professor of Ophthalmology, Queens University Belfast, Ireland: “Innovations in Surgical Trials: Prove It to Me”
Closing Remarks:
Adrienne L. Graves, PhD and Andrew G. Iwach, MD
Co-Founders and Co-Chairs, Glaucoma 360